Venture Capital

With soaring sales for its rare obesity drug IMCIVREE, Rhythm Pharmaceuticals faces a critical March FDA decision that could unlock a massive new market.

New analyses of Upstream Bio's verekitug aim to prove its true effectiveness for nasal polyps, setting the stage for a competitive showdown.

Semiconductor firm Aeluma will meet investors at the ROTH conference, betting its unique, scalable chip technology is the key to powering the future of AI and AR/VR.

Zoomcar's latest financing move involves complex warrants, raising questions about shareholder dilution and its strategy in India's car-sharing race.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

India's Tejas Networks will supply 5G radios to Japan's NEC, a deal signaling a major shift in global supply chains and a win for open network standards.

PROCEPT BioRobotics reports record Aquablation procedures but lowers 2026 revenue guidance, signaling a strategic shift for long-term profitability.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

With record revenue and key battery tech milestones met, Enovix is on the brink of powering smartphones, but manufacturing hurdles and cash burn remain.

Quantum firm IonQ shatters revenue goals with $130M in 2025 and moves to acquire a chip foundry, signaling an aggressive push to own the quantum stack.

With its CFO at a key forum, Syntiant leverages 100M+ chip deployments to prove the value of on-device intelligence in a booming multi-billion dollar market.

Profitmind raises $9M Series A led by Accenture to scale its agentic AI, promising to end data paralysis and revolutionize retail decision-making.

Despite lithium market weakness, AMG Critical Materials' adjusted EBITDA surged 40%, showcasing the power of its diversified portfolio and a strategic pivot.

Oat Foundry launches Chroma Flap, a vibrant kinetic wall that uses mechanical motion and sound to transform interiors into living, multi-sensory art.

With new nostalgic flavors, key hires, and a powerful distribution network, Nixie is moving from natural food aisles to take on the conventional soda market.

Celebrating its 40th anniversary, the Ricordi® Chamber not only transformed diabetes research but now serves as the foundation for the future of cell therapy.

A new analysis shows security teams are drowning in alerts while attackers target a tiny fraction of bugs. This report redefines cyber risk prioritization.

A new exclusive deal pairs NeutronX's AI and federal access with NextNRG's energy tech, aiming to overhaul critical U.S. infrastructure and national security.

The well-funded mealtime innovator Wonder is betting big on Texas, promising thousands of jobs. But can its unique model conquer a crowded market?